Material
T he Th1-Th2 paradigm has dominated the study of immune-mediated resistance to infection for almost 20 y (1, 2) . With the initial description of IL-17 as a cytokine produced by T cells (2-4), it was not clear how this proinflammatory factor related to the biology of established Th subsets (5, 6) . Early reports identified a role for IL-17 in the development and recruitment of neutrophils to sites of inflammation (7, 8) , but studies by Cua and colleagues highlighted the ability of IL-17-producing CD4 + T cells, termed Th17 cells, to contribute to the development of inflammation in models of rheumatoid arthritis and experimental allergic encephalomyelitis (9, 10) . It is now appreciated that there are additional cellular sources of IL-17 that contribute to a variety of inflammatory conditions, including CD8 + T cells (11, 12) , gd T cells (13) , and more recently invariant NKT cells (iNKTs) (14) (15) (16) .
Although IL-17 has been implicated in the pathology associated with various forms of infection-induced inflammation (11, 17) , it has also been linked to resistance to multiple pathogens, including Klebsiella pneumoniae (18) , Candida albicans (19) , and Toxoplasma gondii (20) . The development of a protective host response to intracellular pathogens requires the coordinated action of the innate and adaptive immune system. For many pathogens, the interaction between dendritic cells (DCs), macrophages, NK cells, and neutrophils provide a limited mechanism of innate resistance during the early stages of infection, and also influence the development of adaptive immunity required for long-term protection (21) (22) (23) . Relatively little is known about the role of IL-17 in these early events, but IL-17R 2/2 mice challenged with T. gondii have an early defect in neutrophil recruitment to the local site of infection and an increased parasite burden (20) . Given reports that neutrophils play an important role in innate immunity to toxoplasmosis (24, 25) , studies were performed to characterize the early cellular sources of IL-17 during toxoplasmosis. The comparison of C57BL/6 and C57BL/6 RAG 2/2 mice, which lack T and B cells, revealed that NK cells were major contributors to the production of IL-17. This observation led to further experiments that established that many of the events that promote T cell secretion of IL-17 also induce the secretion of this cytokine from NK cells. In addition, these findings highlight the prominent role of IL-6 in this regulatory pathway and describe a new role for this pleotropic cytokine during innate responses to an intracellular parasitic pathogen.
Materials and Methods

Parasites and infection
C57BL/6 (National Cancer Institute or from The Jackson Laboratory, Bar Harbor, ME), C57BL/6 RAG1 2/2 (C57BL/6 12957-RAG1 tm1 Mom/j) (The Jackson Laboratory), or C57BL/6 IL-6 2/2 mice (The Jackson Laboratory) were infected with 20 cysts of the ME49 strain of T. gondii i.p. as previously described (26) . For in vitro studies, a soluble Toxoplasma Ag (STAg) (50 mg/ml) that was prepared from the RH strain of T. gondii was used as previously described (27, 28) and tested for the absence of LPS and Mycoplasma contaminants by the University of Pennsylvania Cell Center (Philadelphia, PA).
Abs and flow cytometry
The FITC-labeled Abs used were as follows: NK1.1, CD3, CD4, CD8, CD11b, CD11c, and CD19. PE-labeled Abs were as follows: Gr-1, CD126 (anti-mIL-6Ra), RORgt, and IL-17. Biotinylated Abs were as follows: IL6Ra and Rat IgG2a. Allophycocyanin-labeled Abs were as follows: F4/80, CD130 (anti-mgp130), IL-12Rb2, and IFN-g. An Alexa 647-labeled Ab was used to detect T-bet, whereas a PerCP-labeled Ab was used to assay expression of CD3, and a pacific blue-labeled Ab was used to detect NK1.1. All Abs were obtained from eBioscience (San Diego, CA) or R&D Systems (Minneapolis, MN). To assay cytokine production, cells were pulsed with PMA (50 ng/ml; Sigma-Aldrich, St. Louis, MO) and ionomycin (500 ng/ml; Sigma-Aldrich). Two hours later cells were treated with brefeldin A (10 mg/ml; Sigma-Aldrich), incubated for an additional 2 h, and then used for flow cytometry. For intracellular staining, surface-stained samples were washed, fixed and then permeabilized with 0.1% saponin in FACS buffer before staining for cytokine production as routinely performed in this laboratory (29) . Flow cytometric analysis was performed on a FACSCalibur or FACSCantoII (BD Biosciences, San Jose, CA) instrument and analyzed using FlowJo software (TreeStar, Ashland, OR ).
Analysis of NK cell production of cytokines
For depletion of NK cells in vivo, 50 mg of a rabbit anti-asialo GM1 antiserum (WAKO, Richmond, VA) was administered i.p. 1 d prior to infection and thereafter every 3 d in a volume of 0.2 ml for the duration of the experiment. The depletion of NK cells were confirmed by flow cytometry on day 5 postinfection.
To assess NK cell responses in the presence of accessory cells, splenocytes from uninfected or infected RAG 2/2 mice (day 5 postinfection) were prepared as previously described (30) . These cells were cultured in RPMI 1640, (Life Technologies, Gaithersburg, MD) supplemented as previously described (30) , and stimulated with STAg alone (50 mg/ml) or in the presence of the following cytokine neutralizing Abs: anti-IL-12/23p40 (10 mg/ml), anti-IL-12p19 (10 mg/ml), anti-TGF-b (10 mg/ml), or various cytokines, including IL-2 (100 U/ml) (R&D System), IL-6 (50 ng/ml) (eBioscience), IL-15 (10 ng/ml) (eBioscience), IL-23 (10 ng/ml) (eBioscience), IL-27 (100 ng/ml) (Amgen, Thousand Oaks, CA), or TGF-b (1 ng/ml) (eBioscience). After 20 h in culture, IL-17A and IFN-g were assayed by ELISA (eBioscience). , and CD19 + cells. The spleen cells were incubated for 20 min with FITC conjugated Abs, before the addition of anti-FITC magnetic beads and then applied to a magnetic column (Polysciences). After elution, the resulting cell preparation was washed two times with RPMI 1640, (Life Technologies) supplemented as previously described (30) and routinely provided cells with .90% purity, based on staining with NK1.1.
Quantitative real-time PCR analysis
Quantitative real-time PCR of total cellular RNA from splenocytes or purified NK cells isolated from uninfected or infected (day 5 postinfection) RAG 2/2 mice was performed using standard procedures (31) . Expression of RORgt, IL-6, IL-23, and TGF-b were determined with primers obtained from Qiagen (Valencia, CA) using an AB7500 fast real-time PCR thermal cycler and power SYBR green reagents (Applied Biosystems, Foster City, CA). The housekeeping gene encoding b-actin was used as a normalization control.
Statistical analysis
The Student t test for two samples with unequal variance was used to determine statistical significance.
Results
NK cells are an early source of IL-17 during toxoplasmosis
To evaluate the early source of IL-17 during toxoplasmosis, C57BL/6 and RAG 2/2 mice were infected with the ME49 strain of T. gondii and serum levels of IL-17 were measured at days 5 and 7 postinfection by ELISA. In uninfected mice, there were low basal levels of IL-17A, but after challenge, there was a marked increase in the level of circulating IL-17 in both sets of mice (Fig. 1A) . but there was minimal production of IL-17 by these cell types. By day 5 postinfection, the frequency of IFN-g + CD3 + T cells was decreased but a small population of IL-17 + T cells was detected. However, at this early time point, infection resulted in an increased frequency of IFN-g-and IL-17-producing NK cells, but dual cytokine producers were not detected (Fig. 1B) . To directly test the contribution of NK cells to the production of IL-17, C57BL/6 and RAG 2/2 mice were treated with anti-asialo GM1 starting 1 d prior to infection to deplete this population, and serum levels of IL-17 were measured on day 5 postinfection. In this study, the depletion of NK cells led to a 95% reduction in NK1.1 + cells as evaluated by flow cytometry (data not shown), and led to a 65% and 77% reduction in serum IL-17 in C57BL/6 or RAG 2/2 mice, respectively ( Fig. 2A ). When splenocytes from C57BL/6 or C57BL/6 RAG 2/2 mice were restimulated on day 5 postinfection with STAg in vitro, IL-17 production was detected, and furthermore, the depletion of NK cells reduced IL-17 production by 40% and 88%, respectively ( Fig. 2B, 2C ). The differences in the relative contribution of NK cells in these experiments likely reflects the ability of IL-17-producing T cells to expand in vitro, whereas NK cell expansion in these cultures is not observed. Consistent with previous studies in IL-17R 2/2 mice (17), the administration of an anti-IL-17 Ab to infected RAG 2/2 mice resulted in an ∼40% decrease in the infection-induced infiltration of neutrophils into the peritoneum cavity (Supplemental Fig. 1 ). Taken together, the flow cytometric data and the depletion studies identify NK cells as a physiologically significant source of IL-17 during toxoplasmosis.
Factors that regulate NK cell production of IL-17
To better understand the events that promote NK cell production of IL-17, the factors that influence the ability of splenocytes from uninfected or infected RAG 2/2 mice to secrete IL-17 in response to STAg were examined. When cells from uninfected RAG 2/2 mice were stimulated with STAg, low basal levels of IL-17 were detected, whereas splenocytes from infected mice produced 6-fold higher amounts (Fig. 3A) . This latter effect was dependent on the presence of accessory cells, as the ability of STAg to induce IL-17 was reduced when only enriched populations of NK cells were used (Fig. 3B ). This finding suggested that NK cells required additional signals from accessory cells to produce IL-17. Previous studies have established that multiple accessory cell-derived cytokines, such as IL-6, IL-23, and TGF-b, promote the development and maintenance of Th17 cells (10, (33) (34) (35) (36) . To determine the possible role of these cytokines in this experimental system, splenocytes from RAG 2/2 mice infected for 5 d were cultured with STAg and the effects of specific neutralizing Abs on the production of IL-17 were assessed. In these experiments, treatment with anti-IFN-g had no effect (data not shown), but the addition of anti-IL-6 resulted in a marked decrease in IL-17 production (Fig. 3C) . The use of anti-IL-12/23p40 or anti-IL23p19 also resulted in a decrease in IL-17 secretion, implicating IL-23 in these events. Similarly, the blockade of TGF-b also led to a reduction in IL-17 levels. Stimulation of RAG splenocytes with STAg resulted in secretion of IL-6 (media = 51 6 7 pg/ml; STAg = 123 6 31 pg/ml) and to increased levels of IL-6 and IL-23 mRNA but not TGF-b (Supplemental Fig. 2 ). These findings are consistent with previous studies (37, 38) and although TGF-b production is regulated posttranscriptionally, this stimulus does lead to the production of biologically active TGF-b (39). These results suggest that at least three cytokines (IL-6, IL-23, and TGF-b) serve to promote NK cell IL-17 production. To complement the findings described previously, additional experiments were performed to assess the effects of exogenous cytokines on the production of IL-17. Supernatants of cultured splenocytes from uninfected or infected RAG 2/2 mice incubated alone or in the presence of various cytokines for 20 h were used to measure the secretion of IL-17. The inclusion of exogenous IL-1b or IL-18 did not promote IL-17 (data not shown), but the addition of IL-6, IL-23, or TGF-b alone to RAG 2/2 splenocytes from uninfected mice led to low level IL-17 production compared with splenocytes incubated without any cytokines and the combination of all three cytokines led to the highest levels of IL-17 (Fig. 3D) . When similar conditions were used for splenocytes from infected RAG 2/2 mice, each of these stimuli led to approximately three times more IL-17 being produced than observed with uninfected splenocytes (Fig. 3D) . When IFN-g levels were measured under these same conditions, IL-6 and IL-23 both enhanced the levels of IFN-g in these culture supernatants whereas TGF-b had no effect (Supplemental Fig. 3 ). Similar conditions were used with purified NK cells and although these cytokines alone can promote IL-17, a difference between cells from uninfected or infected mice was not apparent (Fig. 3E) . Moreover, when bone marrow-derived macrophages or DCs were preincubated with STAg and then cocultured with purified NK cells, these conditions also led to increased secretion of IL-17 with the most significant effect observed with DCs ( Supplemental Fig. 4 ). Taken together, these results are consistent with a model in which the ability of STAg to stimulate accessory cells to produce IL-6, IL-23, and TGF-b leads to NK cell secretion of IL-17. Although the data described previously identified cytokines that promote NK cell secretion of IL-17, experiments were performed to assess whether known antagonists (IL-2 and IL-27) of Th17 cells (17, 40, 41) also influenced NK cells. For these studies, IL-6 was selected as the primary stimulus as it was the most potent single cytokine that promoted NK cell synthesis of IL-17. As shown in Fig. 3F , the addition of IL-6 alone to splenocytes from infected RAG 2/2 mice increased levels of IL-17 and the addition of IL-2, or its close relative IL-15, had a profound dose-dependent suppressive effect. A similar activity was observed when IL-27 was used (Fig. 3F) . Thus, it appears that the same factors that limit Th17 activity are also relevant to NK cells. NK cells from infected RAG 2/2 mice for 6 h. ELISA for IL-17 revealed that DCs, more than macrophages, are able to restore NK cell IL-17 production (Supplemental Fig. 4 ).
The role of IL-6 in the regulation of the NK cell response
The results described in the previous section identified NK cells as a source of IL-17 during acute toxoplasmosis and indicated a key role for IL-6 in these events. To better understand how IL-6 promoted a fraction ofNKcellstoproduceIL-17,the surfacelevelsofthetwocomponentsof the IL-6R, IL-6Ra, and gp130 (42) on NK cells from uninfected and infected mice was assessed. In uninfected mice, almost all NK cells expressed gp130, but only a subset expressed the a-chain (Fig. 4A) . After challenge, gp130 expression remained constant, but there was an ∼2-fold increase in the frequency of cells that express the IL-6Ra -chain, which was observed across multiple experiments (Fig. 4A, 4B) . Interestingly, although the IL-17 + and IFN-g + NK cells appear to be distinct populations (Fig. 1B) , the IL-6Ra + population of NK cells also express the IL-12Rb2-chain (Fig. 4C) .
When NK cell expression of the transcription factor RORgt, a master regulator of Th17 cells (43), was examined NK cells The Journal of Immunologyfrom uninfected or infected RAG 2/2 mice displayed basal levels of RORgt mRNA transcripts (Fig. 5A) . Stimulation of these cells with IL-23 or TGF-b did not alter RORgt expression, but the addition of IL-6 resulted in a 100-fold elevation in RORgt mRNA levels (Fig. 5A ). When intracellular staining was used to compare levels of T-bet and RORgt in NK cells from uninfected mice, this analysis revealed that there is a subpopulation of NK cells that are RORgt + but which express low levels of T-bet and these cells expand in response to infection (Fig. 5B) . Although intracellular staining for these transcription factors resulted in a reduced ability to detect IL-6Ra (data not shown) by gating on the T-bet + cells, this population expressed the lowest levels of the IL-6Ra-chain. Conversely IL-6Ra expression was highest on the RORbt + cells. (Fig. 5C ). Although these data have to be interpreted with care, they suggest a model in which the ability of NK cells to produce IL-17 is associated with the expression of the IL-6Ra, RORgt and the absence of T-bet.
To evaluate the biological significance of the effects of IL-6 on NK cells, wild-type C57BL/6 mice and IL-6 2/2 mice were infected and on days 3, 5, and 7 postinfection serum levels of IL-17 were analyzed (Fig. 6A) . In these experiments, the absence of IL-6 led to decreased serum levels of IL-17. In addition, the frequency of NK and T cells producing IL-17 were analyzed by flow cytometry in naive C57BL/6 mice and IL-6 2/2 mice infected for 6 d (Fig. 6B ). There was a sizeable decrease in the frequency of IL-17-producing CD3 + T cells as well as by NK1.1 + cells in comparing wild-type C57BL/6 mice with IL-6 2/2 mice (Fig. 6B) .
Together, these data confirm the importance of IL-6 for Th17 differentiation, and provide new insights into its role in the regulation of NK cell IL-17 production.
Discussion
The initial report in which the IL-17R 2/2 mice were challenged with T. gondii indicated a role for IL-17 in the mobilization of neutrophils required for resistance to this pathogen (20) (21) (22) . In those studies, the source of IL-17 was not addressed, but subsequent work indicated that CD4 + and CD8 + T cells produced this factor during chronic toxoplasmosis (17) . In other experimental models, gd and iNKTs also secrete IL-17 (14, 44) but, to the best of our knowledge, there have been no reports that NK cells produce IL-17. Consequently, the identification of NK cells as a relevant source of IL-17 during acute toxoplamosis was unexpected. Studies from multiple laboratories identified NK cells as an important source of IFN-g and necessary for innate resistance to T. gondii (45) (46) (47) (48) as well as other intracellular pathogens, including Listeria monocytogenes (49) and T. cruzi (50) . This led to a body of work that defined the events that promoted this pathway of resistance, and the development of a model in which the recognition of microbial Ags by macrophages and DCs leads to the production of a number of proinflammatory cytokines, including IL-12, which promote NK cell synthesis of IFN-g (48, 51, 52) . The data presented in this study suggest a similar series of events, whereby infection with T. gondii and/or parasite-derived Ags lead to accessory cell production of IL-6 and IL-23, two cytokines related to IL-12 (53) , which in combination with TGF-b promote IL-17 production by a distinct population of NK cells. It is notable that splenocytes derived from infected RAG mice routinely produced more IL-17 in response to STAg than those from uninfected mice. Perhaps the simplest explanation is that there are higher basal levels of proinflammatory factors present in the cultures from infected mice. Another possibility is that during toxoplasmosis, the splenic accessory cells produce additional cytokines/ cofactors that cooperate with IL-6, IL-23, and TGF-b to promote IL-17 secretion.
Given the common cytokine and signaling pathways that drive NK and T cell production of IFN-g, it is not surprising that some of the same elements that are relevant to Th17 differentiation are also pertinent to NK cells. Thus, IL-6, IL-23, and TGF-b are all associated with promoting or maintaining Th17 responses, and the ability of IL-6 to induce expression of mRNA transcripts for RORgt, the Th17 master regulator, in NK cells highlights the common molecular pathways that are relevant to IL-17 production. Interestingly, although we have focused on the effects of IL-6 to support an IL-17 response, a recent report concluded that IL-6 does not promote the ability of iNKTs to produce IL-17 (16) . This latter observation is consistent with the description of IL-6-independent circumstances that promote Th17 cells (54) , and suggests that the relative contribution of different cell populations to the pool of IL-17 is profoundly influenced by the local cytokine response. In addition, the shared biology of T and NK cell populations is also relevant to antagonists of Th17 cells. Thus, IL-2 and IL-27 are potent antagonists of T cell production of IL-17 (17, 41, 55) , and, along with IL-15, have a similar inhibitory effect on NK cells. Taken together, these data indicate that the same pathways that have been shown to regulate T cell production of IL-17 are also relevant to the TCR-independent process in NK cells.
It is relevant to note that although others have previously shown that NK cells express the IL-6R (56), there is remarkably little known about the functional effects of IL-6 on these cells. Previous reports have highlighted that although IL-6 has no effect on cytotoxicity, it does enhance NK cell adhesion and proliferation when combined with IL-15 in vivo (57 (58) and an increased susceptibility to toxoplasmosis (59, 60), One possible explanation for this outcome is that the increased susceptibility of these mice to T. gondii may be a result of the absence of IL-17 and, consequently, reduced neutrophils, a notion that has yet to be tested directly. In the last 15 y, there has been an increased appreciation of the functional role of NK cells in promoting resistance to infection and tumor surveillance. The data presented in this study add the production of IL-17 to that list. These studies also contribute to the idea that there are distinct subsets of NK cells that can be defined based on their capacity to produce distinct patterns of cytokines (61) (62) (63) . The characterization of the expression patterns of activating and inhibitory receptors (64) as well as the IL-12Rb2-chain (65) has indicated the existence of multiple NK cell subsets. The observation that only a portion of resting NK cells express both chains of the IL-6R, and that IL-17 + IFN-g + double producers were not observed as well as the distinct pattern of T-bet and RORgt expression in NK cells supports this idea. Thus, in contrast to T cells, in which a naive T cell can adopt a multitude of cell fates (Th1, Th2, Th17, follicular Th, T regulatory), it seems possible that NK cells may be hard wired to produce certain combinations of cytokines that provide the innate equivalent of distinct T cell subsets. This may be most apparent during a challenge with pathogens like T. gondii where a prominent population of IFN-g + NK cells is present (48) , whereas during helminth infection, these lymphocytes are a potent source of IL-13 (66) . Those previous studies, and those presented in this study, have not yet distinguished whether a mature NK cell has the potential to produce IFN-g, IL-13, or IL-17 or acquires a more exclusive phenotype through education or development. Regardless, NK cells provide a model to study the events that influence cytokine production and may provide new insights into the mechanisms that regulate this pathway without the confounding factor of TCR and costimulation requirements.
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